Patents Examined by Randall Winston
  • Patent number: 9943602
    Abstract: The present invention is embodied by a composition capable inducing weight loss in a patient in need thereof.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: April 17, 2018
    Assignee: SDG, Inc.
    Inventors: W. Blair Geho, John R. Lau
  • Patent number: 9943553
    Abstract: To provide a method for producing an oyster meat essence that more amply incorporates an antioxidant substance with high ORAC value as follows. A portion of an oyster meat extract more amply incorporating an antioxidant substance with high ORAC value is selected. An extraction method that allows incorporating further large amount of antioxidant substance with high ORAC value is employed. The beneficial oyster meat extract can be efficiently extracted in large amounts. Object An oyster meat is stored in an extraction container where water is accumulated. An oyster meat essence is extracted to generate an extract liquid. The extract liquid is injected to a centrifuge, and concurrently the centrifuge is rotated at a centrifugal acceleration where an antioxidant substance with high antioxidative potency and ORAC value is separated and removed from the extract liquid. The antioxidant substance with higher antioxidative potency and ORAC value is separated.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: April 17, 2018
    Assignee: WATANABE OYSTER LABORATORY CO., LTD.
    Inventors: Mitsugu Watanabe, Takayuki Watanabe, Hideaki Watanabe
  • Patent number: 9937210
    Abstract: The present invention relates to a method for isolating a fraction having anti-inflammatory or osteoarthritis-inhibiting effects by removing impurities and washing oyster shells, which are produced during a process of producing oysters, drying same, forming a powder from the oyster shells, and adding anhydrous citric acid to same for a reaction, obtaining a reaction product, and isolating a supernatant, which is obtained by centrifugally separating the reaction product, by means of ultrafiltration. By adding the anhydrous citric acid to the oyster shell chips for the reaction at a relatively low temperature, the present invention provides superior advantages, such as significantly reducing energy costs and isolating the fraction having the anti-inflammatory or osteoarthritis inhibiting effects through a simple method.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: April 10, 2018
    Assignee: Seojin Biotech Co., Ltd.
    Inventors: Hak-Ju Kim, Ji-Sook Han, Yeoun-Ju Byoun
  • Patent number: 9913867
    Abstract: The present invention relates to a composition comprising an extract of a mixture of Undaria pinnatifida sporophylls and ascidian shells for treating atopic dermatitis, wherein the composition has the excellent effect of treating atopic dermatitis through the synergistic interaction of the anti-inflammatory effect of Undaria pinnatifida sporophylls and the cell regenerative effect of ascidian shells. The composition of the invention is not involved in the suppression of cytokine production. However, it is assumed that the composition has the effects of suppressing inflammation as well as regenerating skin.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: March 13, 2018
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
    Inventors: Beyong-dae Choi, Seong-hun Jeong, Shi-hyang Park, Myung-sook Kim, Soon-ok Choi
  • Patent number: 9907827
    Abstract: The present invention refers to a prebiotic mixture comprising at least one plant polysaccharide fiber and at least one of Propolis and/or Olea europaea and/or Aloe vera extracts, optionally comprising also Thymus vulgaris and/or Agrimonia eupatoria extracts. Moreover, the present invention also relates to said mixture for use in the preservation and/or in the restoration of the intestinal microbiota balance.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: March 6, 2018
    Assignee: ABOCA S.P.A. SOCIETÁ AGRICOLA
    Inventors: Valentino Mercati, Valentina Mercati, Andrea Lugli, Anna Maidecchi
  • Patent number: 9895405
    Abstract: Present invention relates to a use of Radix Salviae Miltiorrhizae (Danshen) or its preparations in preparation of drugs for treating disease related to hepatic fibrosis.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: February 20, 2018
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Yonghong Zhu, Jinfang Hu, Jie Ma, Xiuping Shen
  • Patent number: 9895421
    Abstract: The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: February 20, 2018
    Assignee: University-Industry Cooperation Group of Kyung Hee University
    Inventors: Jin Ju Kim, Eun Jung Ko, Eui Jeoung Lee
  • Patent number: 9889173
    Abstract: The present invention provides a composition for improving macular pigment optical density and preventing or treating age-related macular optical degeneration. The composition comprises lutein, zeaxanthin and tea extracts, wherein the weight ratio of zeaxanthin to lutein is more than or equal to 1. The composition may prevent formation of choroidal neovascularization to achieve effects on comprehensively preventing or treating age-related macular optical degeneration (AMD).
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: February 13, 2018
    Assignee: Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
    Inventors: Xinde Xu, Lihua Zhang, Xiaoxia Sun
  • Patent number: 9877914
    Abstract: Disclosed is a topical skin composition comprising water, a first algae extract comprising Crithmum maritimum, a second algae extract comprising Ulva lactuca, and a third algae extract.
    Type: Grant
    Filed: February 18, 2013
    Date of Patent: January 30, 2018
    Assignee: Mary Kay Inc.
    Inventor: Gopa Majmudar
  • Patent number: 9861116
    Abstract: The invention relates to pet food compositions designed to induce the animal to cease feeding upon consumption of the appropriate nutritional amount. The invention further provides methods of inducing satiety response in animals and methods of controlling the amount of food intake in animals.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: January 9, 2018
    Assignee: Hill's Pet Nutrition, Inc.
    Inventor: Samer Al-Murrani
  • Patent number: 9855307
    Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: January 2, 2018
    Assignee: Izun Pharmaceuticals Corporation
    Inventors: William Z. Levine, Aron J. Saffer, Mina Fran
  • Patent number: 9839663
    Abstract: Disclosed is a combination of lipophilic extracts of Zingiber officinale and Echinacea angustifolia for the treatment of itching, peripheral pain, superficial and deep inflammatory and painful states, pain associated with muscle spasms, herpes pain, and radiodermatitis caused by oncological radiotherapy, with or without fungal or bacterial infections.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: December 12, 2017
    Assignee: INDENA S.P.A.
    Inventors: Ezio Bombardelli, Paolo Morazzoni
  • Patent number: 9839604
    Abstract: An anti-aging composition comprising: pinebark extract, polypodium leucotomos, ashwagandha extract, dehydroepiandrosterone, white tea extract, alpha lipoic acid, vitamin K2, bioactive silicon, hyaluronic acid, trimethylglycine, and optionally, piperine, green tea extract, folic acid, vitamin C, camu camu, and blueberry extract.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: December 12, 2017
    Inventor: Parham Michael Tabibian
  • Patent number: 9839659
    Abstract: A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in treating women's menopausal symptoms, due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the treating effect of the pomegranate extract on women's menopausal symptoms. The method includes increasing the content of ellagic acid in the pomegranate extract.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: December 12, 2017
    Assignees: HEALTH-LOVE CO., LTD.
    Inventor: Hae-Yeon Lee
  • Patent number: 9821017
    Abstract: An extract of Asplenium nidus L. includes pyropheophorbide a methyl ester (C34H36N4O3), pheophorbide a methyl ester (C35H36N4O5), 1-linleoyl-3-linolenoyl-glycerol (C39H66O5), 1-linleoyl-2,3-dipalmitoyl-rac-glycerol (C53H98O6) and 1,3-dipalmitoyl-sn-glycerol (C35H68O5). The extract of Asplenium nidus L. is obtained by using a method including steps of: solvent extraction, using an solvent to extract an Asplenium nidus L. sample and to obtain an extract, with a w/v ratio between the solvent and the Asplenium nidus L. sample being 50˜60 mg/ml; and column chromatography, fractionating the extract with water and ethanol as eluent to obtain several fractions including fraction a to fraction i, and further evaporating and lyophilizing fraction b, c, d or their combination to obtain an extract of Asplenium nidus L.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: November 21, 2017
    Assignees: Jin Xin Biotechnology Co., Ltd., Academia Sinica
    Inventors: Kun-Hsuan Huang, Tza-Zen Chaung, Pei-Wen Hsiao, Chia-Jui Tsai
  • Patent number: 9814742
    Abstract: The present invention relates to a diet product comprising an alginate in an aqueous dissolved or swelled form at a pH value causing the alginate not to gel until after it is consumed and comes into contact gastric acid.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: November 14, 2017
    Assignee: S-Biotek AF 15. Marts 2006 1 APS
    Inventor: Jens Steen Olsen
  • Patent number: 9808499
    Abstract: The present invention relates to oriental medicine compositions marked as SEC 22 and SEC 33 for improving digestive functions and respiratory functions for improving children's underweight, low growth and depressed respiratory organ, an oriental medicine derived therefrom, and methods of preparing them. According to an example of the present invention, the oriental medicine composition containing broiled fruit of Crataegus pinnatifida, broiled root of Atractylodes japonica, dried peel of Citrus unshiu, broiled sprout of Hordeum vulgare, broiled fruit of Amomum xanthioides, root of Zingiber officinale, dried fruit of Zizyphi, and horn of Cervus elaphus.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: November 7, 2017
    Inventor: Kijoon Kim
  • Patent number: 9795649
    Abstract: The present invention relates to a novel use of sesquiterpenoid compounds, the pharmaceutically acceptable salts thereof, or the extracts of Cyperus rotundus comprising same or the fractions thereof in the prevention or treatment of menopausal diseases. The sesquiterpenoid compound according to the present invention, the extracts of Cyperus rotundus comprising the same or fractions thereof exhibit excellent estrogenic activity or anti-allergic activity, and therefore they can be used for the prevention or treatment of menopausal diseases caused by a decline in estrogen level or by allergic diseases.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: October 24, 2017
    Assignee: Research & Business Foundation Sungkyunkwan University
    Inventors: Kyu Hyuck Chung, Jong Hwan Kwak
  • Patent number: 9770047
    Abstract: A composition of matter comprises a shelf stable, partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of perilla frutescens, the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: September 26, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 9770478
    Abstract: The invention relates to a novel use of the Chinese herb Glycyrrhiza inflata in treatment of neurodegenerative disorders. Particularly, the invention relates to the use of ammonium glycyrrhizinate and licochalcone A in targeting polyQ-mediated spinocerebellar ataxia.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: September 26, 2017
    Assignee: NATIONAL TAIWAN NORMAL UNIVERSITY
    Inventors: Guey-Jen Lee-Chen, Chiung-Mei Chen